Active Ingredient Purpose
Benzoyl Peroxide - 10.00% Acne Treatment
The following Structured Product Label (SPL) was submitted to the FDA by Rite Aid for the product Vanishing Acne Treatment (NDC 11822-1229). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient purpose, when using this product, directions, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Benzoyl Peroxide - 10.00% Acne Treatment
• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • rinse right away with water if it gets in eyes • avoid unnecessary sun exposure and use a sunscreen •avoid contact with eyes, lips, and mouth • avoid contact with hair and dyed fabrics, which may be bleached by this product • skin irritation may occurs, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
• cleans the skin thoroughly before applying medication • cover the entire affected area with a thin layer one to three times a day • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. • if going outside, use a sunscreen. Allow product to dry, then follow direction in the sunscreen labeling. If sensitivity develops, discontinue use of both products and consult a doctor.
Aluminum Hydroxide, Bentonite, Carbomer, Glyceryl Stearate SE, Isopropyl Myristate, Methylparaben, PEG-12, Potassium Hydroxide,
Propylene Glycol, Propylparaben, Water
* Please review the disclaimer below.